News-2 - StoneWise AI

Latest News

From Technological Breakthrough to Industrial Innovation: StoneWise's MolVado Small-Molecule Drug Design Platform Debuts at HUAWEI CONNECT 2025, Defining a New Height in AI-Powered Drug Discovery

2025-09-24
AI Reconstructs Drug Discovery The Transformation from Theoretical Breakthrough to Clinical Value [July 9th AI Half-Month Talk] Grand Launch

2025-07-09
Stonewise Debuts at AIBC2025, Focusing on Two Core Challenges of Molecular Generation Models Data and Evaluation

2025-06-18
IND Approval | StoneWise's Self-Developed Oral Small-Molecule SWA1211 Secures Clinical Trial Approvals in China and the US

2025-06-13
Events| 2021 ACS Fall Meeting

2021-08-20
StoneWise Raises $100 Million to Boost AI-driven Drug Innovation

2021-04-11

Total of 14 entries, total of 3 pages

Academic progress

Total of 22 entries, total of 4 pages

Start Your Intelligent Drug Development Journey

MolVortex Early Drug Discovery Agent – Empowering Your R&D Breakthroughs

产品&服务

StoneWise (HK) Limited

BD Inquiries: bd@stonewise.cn

Customer Service: support@stonewise.cn

Investment Inquiries: ir@stonewise.cn

Media Inquiries: pr@stonewise.cn

Address (Beijing): 2nd Floor, Zhongguancun Dream Lab, No.1 Haidian Street, Haidian District, Beijing

Address (Shanghai): A3018, No. 1077 Zhang Heng Road, Pudong New Area, Shanghai

StoneWise (HK) Limited

BD Inquiries: bd@stonewise.cn

Customer Service: support@stonewise.cn

Investment Inquiries: ir@stonewise.cn

Media Inquiries: pr@stonewise.cn

Address (Beijing): 2nd Floor, Zhongguancun Dream Lab, No.1 Haidian Street, Haidian District, Beijing

Address (Shanghai): A3018, No. 1077 Zhang Heng Road, Pudong New Area, Shanghai